914948-32-6Relevant articles and documents
Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation
Keck, Thomas M.,Zou, Mu-Fa,Zhang, Peng,Rutledge, Rebecca P.,Newman, Amy Hauck
supporting information; experimental part, p. 544 - 549 (2012/09/05)
Negative allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGluR5) have shown promising results in preclinical models for anxiety and drug abuse. Here, we describe a series of aryl-substituted alkynyl analogues of the prototypic m
1, 6 -DIHYDRO- 1,3, 5, 6-TETRAAZA-AS-INDACENE BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AS INHIBITORS OF IKK ENZYME ACTIVITY
-
Page/Page column 196-197, (2010/11/24)
The present invention provides for tricyclic compounds having the formula (I) wherein R1, R2, R5, R6, R7, and R8 are as described herein. The present invention further provides pharmaceutical compositions comprising such compounds, as well as the use of such compounds for treating inflammatory and immune diseases.